Primis Financial Corp. (FRST)
Primis Financial Corp. (FRST)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Gain on sale-leaseback of bank premises | NaN | 50,573 | NaN | NaN |
| Loss on sales of investment securities | NaN | -14,777 | NaN | NaN |
| Gains on panacea financial holdings investment | NaN | 20 | 294 | 32,028 |
| Net income | 7,312 | 29,540 | 6,830 | 21,471 |
| Depreciation and amortization | 3,395 | 2,820 | 2,029 | 4,506 |
| Net amortization of premiums and (accretion of discounts) | 38 | -12 | -110 | -175 |
| Proceeds from sales of assets held for sale | NaN | NaN | -1,326 | -982 |
| Provision for credit losses | 1,549 | 2,439 | -49 | 9,899 |
| Loss (gain) on bank premises and equipment and assets held for sale | NaN | 0 | 80 | 111 |
| Originations of loans held for sale | 390,092 | NaN | NaN | NaN |
| Purchases of cloud computing arrangement assets | NaN | 278 | NaN | NaN |
| Proceeds from sales of loans originated to sell | -331,513 | NaN | 0 | -12,224 |
| Gains on other investments | NaN | 33 | 381 | -255 |
| Net gains on loans held for sale | 7,300 | -46,298 | 16,092 | 18,344 |
| Net gains on mortgage banking | 3,460 | 9,992 | 8,887 | 13,508 |
| Net change in fair value of consumer program derivative | NaN | 250 | 768 | 3,334 |
| Net gains on sale of loans originated as held for investment | 567 | 1,470 | 249 | 210 |
| Earnings on bank-owned life insurance | 472 | 466 | 456 | 863 |
| Gain on bank-owned life insurance death benefit | NaN | NaN | 0 | 0 |
| Stock-based compensation expense | 113 | 2,843 | 12 | 49 |
| Deferred income tax expense | -298 | 908 | -1,780 | -5,594 |
| Net increase in other assets | 8,642 | -5,696 | -1,996 | 2,542 |
| Net increase (decrease) in other liabilities | -195 | 2,332 | 96 | 2,308 |
| Net cash and cash equivalents (used in) provided by operating activities | -54,362 | 28,735 | -11,381 | -6,587 |
| Proceeds from bank-owned life insurance death benefit | NaN | NaN | NaN | 0 |
| Proceeds from sales of investment securities | NaN | 129,013 | NaN | NaN |
| Purchases of securities available-for-sale | 8,265 | 73,623 | 0 | 18,460 |
| Proceeds from paydowns, maturities and calls of securities available-for-sale | 6,770 | 9,801 | 8,935 | 18,680 |
| Proceeds from paydowns, maturities and calls of securities held-to-maturity | 185 | 294 | 294 | 585 |
| Net (increase) decrease in frb and fhlb stock | -9,977 | 2,850 | -4,037 | 39 |
| Net change in loans held for investment | 120,487 | 127,243 | 125,273 | 173,799 |
| Purchases of other investments | NaN | NaN | NaN | -164 |
| Proceeds from sales of loans initially originated to be held for investment | 7,366 | 56,634 | 4,191 | 52,902 |
| Proceeds from sales of bank premise and equipment and assets held for sale | NaN | 2,308 | NaN | NaN |
| Proceeds from sale-leaseback of bank premises | NaN | 56,875 | NaN | NaN |
| Purchase of bank-owned life insurance | 7,516 | NaN | NaN | NaN |
| Purchases of bank premises and equipment | 204 | 1,734 | NaN | NaN |
| Proceeds from sale of panacea financial holdings investment | NaN | 0 | 22,091 | NaN |
| Proceeds from sale of other investment | NaN | 0 | 432 | NaN |
| Net decrease in other investments | 80 | 79 | -49 | NaN |
| Repurchase of common stock | NaN | 0 | 0 | 807 |
| Net cash and cash equivalents (used in) provided by investing activities | -132,048 | 55,254 | -93,580 | -119,889 |
| Net increase (decrease) in deposits | 27,480 | 59,233 | -6,321 | 162,091 |
| Proceeds from exercised stock options | NaN | 0 | 15 | 0 |
| Repurchase of restricted stock | NaN | NaN | 0 | 0 |
| (decrease) increase in securities sold under agreements to repurchase | 27 | 402 | 416 | -452 |
| Repayments of secured borrowings, net | -323 | -630 | -1,046 | -746 |
| Repayment of short-term fhlb advances | NaN | NaN | 0 | 0 |
| Cash dividends paid on common stock | 2,559 | 2,464 | 2,464 | 4,945 |
| Proceeds from exercised stock options | 113 | NaN | NaN | NaN |
| Increase in short-term fhlb advances | 205,000 | -60,000 | 85,000 | NaN |
| Issuance of panacea financial holdings stock, net of costs | NaN | NaN | 0 | 0 |
| Repayment of senior subordinated notes | 27,000 | NaN | NaN | NaN |
| Net cash and cash equivalents provided by (used in) financing activities | 202,684 | -4,263 | 74,768 | 156,045 |
| Net change in cash and cash equivalents | 16,274 | 79,726 | -30,193 | 29,569 |
| Cash and cash equivalents at beginning of period | 143,607 | 63,881 | 64,505 | NaN |
| Cash and cash equivalents at end of period | 159,881 | 143,607 | 63,881 | NaN |